Top Markets
#1 Siren Siren +34.93%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.49%
#3 Ribbita by Virtuals Ribbita by Virtuals +18.65%
#4 Cysic Cysic +18.24%
#5 PulseChain PulseChain +17.42%
#6 KUB Coin KUB Coin +16.79%
#7 TROLL TROLL +16.24%
#8 Velvet Velvet +15.28%
#9 BasedHype BasedHype +14.42%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.24%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rank in Stocks #31258
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Share Price
$0.4097
Market Cap
$14.48M
Change (1 day)
-9.16%
Change (1 year)
-67.22%
Country
IL
Trade NeuroSense Therapeutics Ltd. (NRSN)

Category

Healthcare
EPS for NeuroSense Therapeutics Ltd. (NRSN)
EPS as of 2026 TTM: 0
According to NeuroSense Therapeutics Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for NeuroSense Therapeutics Ltd. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE